Sandoz, Others Settle Medicaid Inflation MDL Suits
Sandoz Inc. and other pharmaceutical companies on Friday settled part of a Massachusetts multidistrict litigation alleging the defendants caused the federal government to overpay for Medicaid reimbursements by reporting inflated drug...To view the full article, register now.
Already a subscriber? Click here to view full article